Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -0.395\% human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) COc1ccc(OC)c(S(N)(=O)=O)c1
(b) NNC(=O)c1ccc(O)cc1
(c) Cc1ccc(C(C)C)c(OCC(=O)Nc2ccccc2N2CCN(C)CC2)c1
(d) COc1ccc(Br)cc1C(=O)NC(=S)Nc1ccc(CN2CCOCC2)cc1
Answer: d. COc1ccc(Br)cc1C(=O)NC(=S)Nc1ccc(CN2CCOCC2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
5-bromo-2-methoxy-N-[[4-(morpholin-4-ylmethyl)phenyl]carbamothioyl]benzamide